AI Science Tracker
EN

Application of machine learning in the discovery of antimicrobial peptides: exploring their potential for ulcerative colitis therapy.

Not stated in the abstract reviewed · 29 Dec 2025 · medicine

Discovery

Application of machine learning in the discovery of antimicrobial peptides: exploring their potential for ulcerative colitis therapy.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning-ranked peptide candidates had measured antimicrobial activity and improved outcomes in a DSS mouse-colitis model; this is preclinical evidence, not clinical efficacy.

Technology: Machine-learning sequence prediction/ranking selected candidates for experimental testing; this is the operation linked to the measured outcomes.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Machine-learning sequence prediction/ranking selected candidates for experimental testing; this is the operation linked to the measured outcomes.
Test and result
Selected peptides showed measured antimicrobial activity/stability; treatment improved symptoms and tissue measures in DSS mouse colitis and altered microbiome/metabolites.
Limitation / still unknown
In-vitro assays and a mouse colitis model test candidates; evidence is short-term and preclinical, not human efficacy.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://egastroenterology.bmj.com/content/3/4/e100253.full.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.